Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia.
Bonderman, D
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia. [electronic resource] - European journal of clinical investigation Sep 2006 - 71-2 p. digital
Publication Type: Case Reports; Journal Article
0014-2972
10.1111/j.1365-2362.2006.01683.x doi
Administration, Oral
Adult
Antihypertensive Agents--administration & dosage
Bosentan
Endothelin Receptor Antagonists
Female
Humans
Hypertension, Pulmonary--drug therapy
Middle Aged
Sulfonamides--administration & dosage
Telangiectasia, Hereditary Hemorrhagic--complications
Treatment Outcome
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia. [electronic resource] - European journal of clinical investigation Sep 2006 - 71-2 p. digital
Publication Type: Case Reports; Journal Article
0014-2972
10.1111/j.1365-2362.2006.01683.x doi
Administration, Oral
Adult
Antihypertensive Agents--administration & dosage
Bosentan
Endothelin Receptor Antagonists
Female
Humans
Hypertension, Pulmonary--drug therapy
Middle Aged
Sulfonamides--administration & dosage
Telangiectasia, Hereditary Hemorrhagic--complications
Treatment Outcome